Robert Schickel
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- Cell death mechanisms and regulation
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Cell death mechanisms and regulation 4
- RNA Research and Splicing 2
- Signaling Pathways in Disease 1
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- NF-κB Signaling Pathways 2
- Co-authors
- Marcus E. Peter (8 shared papers)Park Sm (1 shared paper)Brad M. Boyerinas (1 shared paper)Sun-Mi Park (3 shared papers)Christine Feig (4 shared papers)Scott A. Shell (2 shared papers)Ernst Lengyel (2 shared papers)A. Reza Radjabi (2 shared papers)
- Journals
- Current Opinion in Cell Biology (1 paper)The EMBO Journal (1 paper)Cell Cycle (1 paper)Journal of Biological Chemistry (1 paper)Molecular Cell (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Robert Schickel
8 papers receiving 1.7k citations
Robert Schickel's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 1.0k
- Molecular Biology 1.4k
- Immunology 245
- Reproductive Medicine 56
- Oncology 167
Countries citing papers authored by Robert Schickel
This map shows the geographic impact of Robert Schickel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schickel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schickel more than expected).
Fields of papers citing papers by Robert Schickel
This network shows the impact of papers produced by Robert Schickel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schickel. The network helps show where Robert Schickel may publish in the future.
Co-authors
The 19 scholars most cited alongside Robert Schickel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death Hit paper breakdown → | 2008 | 614 |
| 2 | 2007 | 377 | |
| 3 | 2007 | 193 | |
| 4 | 2006 | 192 | |
| 5 | 2010 | 144 | |
| 6 | 2005 | 106 | |
| 7 | 2004 | 57 | |
| 8 | Lee, K. H. et al. The role of receptor internalization in CD95 signaling. EMBO J. 25, 1009-1023 | 2006 | 7 |
About Robert Schickel
Robert Schickel is a scholar working on Molecular Biology, Cancer Research, Immunology, Immunology and Allergy and Infectious Diseases, having authored 8 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers), NF-κB Signaling Pathways (2 papers), RNA Research and Splicing (2 papers), Immune Response and Inflammation (2 papers), Signaling Pathways in Disease (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.4k citations), Immunology (245 citations), Reproductive Medicine (56 citations) and Oncology (167 citations). Robert Schickel has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Marcus E. Peter, Park Sm, Brad M. Boyerinas, Sun-Mi Park, Christine Feig, Scott A. Shell, Ernst Lengyel, A. Reza Radjabi, David A. Jewell and Emily O. Kistner. Their work appears in journals such as Current Opinion in Cell Biology, The EMBO Journal, Cell Cycle, Journal of Biological Chemistry and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.